Evidence map›Paper›PMID 33972452›Full record

ArticleThorax2022

Bronchial gene expression signature associated with rate of subsequent FEV

Elizabeth J Becker, Alen Faiz, Maarten van den Berge, Wim Timens, Pieter S Hiemstra, Kristopher Clark, Gang Liu, Xiaohui Xiao, Yuriy O Alekseyev, George O'Connor and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Thorax, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Mucus plugs-associated gene expression identifies pathophysiology shared with chronic bronchitis.American journal of respiratory and critical care medicine · 2026
    Article
  4. Article
  5. A translational view of airway epithelial dysfunction in COPD.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The role ofHeliyon · 2023
    Article
  11. Endoplasmic reticulum stress: a vital process and potential therapeutic target in chronic obstructive pulmonary disease.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Review
  12. Article
  13. Development of a Blood-based Transcriptional Risk Score for Chronic Obstructive Pulmonary Disease.American journal of respiratory and critical care medicine · 2022
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 4 countries.

Elizabeth J BeckerDivision of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts, USA.
Alen FaizRespiratory Bioinformatics and Molecular Biology (RBMB), School of Life Sciences, University of Technology Sydney, Sydney, New South Wales, Australia.
Maarten van den BergeDepartment of Pulmonary Diseases, University Medical Center Groningen, Groningen, The Netherlands.
Wim TimensDepartment of Pathology and Medical Biology, University Medical Centre Groningen, Groningen, The Netherlands.ORCID 0000-0002-4146-6363
Pieter S HiemstraDepartment of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0002-0238-5982
Kristopher ClarkInternal Medicine Residency Program, Boston Medical Center, Boston, Massachusetts, USA.
Gang LiuDivision of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts, USA.
Xiaohui XiaoDivision of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts, USA.
Yuriy O AlekseyevDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
George O'ConnorDivision of Pulmonary, Allergy, Sleep, and Critical Care Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
Stephen LamBritish Columbia Cancer Agency, Vancouver, British Columbia, Canada.
Avrum SpiraDivision of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts, USA.
Marc E Lenburg *Division of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts, USA.
Katrina Steiling *Division of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts, USA steiling@bu.edu.
Boston University · USUniversity Medical Center Groningen · NLBC Cancer Agency · CABoston Medical Center · USLeiden University Medical Center · NLUniversity of Technology Sydney · AU

Funding

Linking airway genomics to the pathogenesis and clinical heterogeneity of COPDR01HL095388 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI LENBURG, MARC ELLIOTT, SPIRA, AVRUM E · 2008 to 2011
$2.9M
Integrative Omics to Discover Molecular Determinants of COPDR01HL118542 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HACKETT, TILLIE-LOUISE, LENBURG, MARC ELLIOTT · 2013 to 2016
$2.7M
NHLBI NIH HHS R01 HL095388NHLBI NIH HHS R01 HL118542
6 · The paper itself

Abstract

backgroundCOPD is characterised by progressive lung function decline. Leveraging prior work demonstrating bronchial airway COPD-associated gene expression alterations, we sought to determine if there are alterations associated with differences in the rate of FEV

methodsWe examined gene expression among ever smokers with and without COPD who at baseline had bronchial brushings profiled by Affymetrix microarrays and had longitudinal lung function measurements (n=134; mean follow-up=6.38±2.48 years). Gene expression profiles associated with the rate of FEV

resultsExpression differences in 171 genes were associated with rate of FEV

conclusionWe have identified and replicated an airway gene expression signature associated with the rate of FEV

Indexed as

Pulmonary Disease, Chronic ObstructiveTranscriptomeBronchiForced Expiratory VolumeHumansRespiratory Function TestsSmokingairway epitheliumrespiratory measurement

Identifiers

PMID33972452
PMCPMC13021120
OpenAlexW3162596284

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.